Virginia Regulatory Town Hall
Agency
Virginia Racing Commission
Board
Virginia Racing Commission
chapter
Medication [11 VAC 10 ‑ 180]
Action is Exempt from Article 2 of the Administrative Process Act
Action:
To amend regulations pertaining to medication in racehorses.
Action 1259
 
General Information
Action Summary The amendments adopt four new substantive provisions in Medication (11 VAC 10-180-10 et seq.). The provisions are (i) the possessing or administering Erythropietin or any analogous substance is prohibited, (ii) prohibiting the use of "shockwave therapy" devices on racehorses ten days prior to a race, (iii) treating racehorses three hours or less prior to post time, and (iv) restricting the levels of carbon dioxide concentrations in post-race testing.
Chapters Affected Only affects this chapter.
Executive Branch Review This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication.
Exempt Citation: 2.2-4002 (B) (23)
RIS Project No project yet assigned to this action
New Periodic Review This action will not be used to conduct a new periodic review.
 
Stages
Stages associated with this regulatory action.
Stage ID Stage Type Status
2229 Final Stage complete. This regulation became effective on 03/31/2003.
 
Contact Information
Name / Title: Kimberly Mackey  / Regulatory Coordinator
Address: 5707 Huntsman Road
Suite 201-B
Richmond, VA 23250
Email Address: Kimberly.Mackey@vrc.virginia.gov
Phone: (804)966-7406    FAX: ()-    TDD: ()-

This person is the primary contact for this board.